BloFin Futures to List GRVTUSDT: 0 Maker Fees & 50% off Taker Fees!

July 30, 2026 at 11:09 PM

Dear BloFin users,

We are pleased to announce that the USDT-Margined perpetual contract for GRVTUSDT will be listed at 15:30 UTC on Jul 30, 2026.

The updates will cover both the web and app interfaces. The details are as follows:

  • GRVTUSDT Perpetual:
FeatureDetails
Underlying AssetGRVT (Grvt) 
Settlement AssetUSDT
Project InfoGrvt is a self-custodial on-chain wealth platform that combines yield-bearing savings, institutional-grade investment products, and spot and perpetual trading across crypto, equities, and commodities within a single account balance.
Contract Size10 GRVT
Price Quotation10 GRVT value calculated in USDT equivalent
Tick Size0.00001
Leverage1-20X
Funding Fee Settlement FrequencyEvery 4 hours
Trading Hours24/7

🎉Event: Trade GRVTUSDT with 0 Maker Fees & 50% Off Taker Fees

To celebrate the launch of the new trading pair on BloFin Futures, we will offer 0 Maker fees and 50% off Taker fees during the first 48 hours after listing — with Taker fees as low as 0.03%!

Please note:

To experience the innovative power of BloFin, please go to the BloFin website or download the App from the Apple App Store and Google Play Store to trade easily on the go.

Thank you for your support!

BloFin Team

Jul 30, 2026

Find us on:

X (Twitter) · Instagram · Telegram · Discord · Youtube · Facebook · Threads · LinkedIn · TikTok

BloFin reserves the right, in its sole discretion, to amend or cancel this announcement at any time and for any reason without prior notice.

Risk Warning: Digital assets are highly speculative and subject to significant volatility. They may become illiquid at any time, and investors could lose the entire value of their investment. Before trading any digital asset, you should conduct your own research and assess your risk tolerance. BloFin is not liable for any losses you may incur from trading digital assets. This material should not be construed as financial advice. For more information, view our Terms of Use and Risk Warning.

Was this article helpful?